78 reports of this reaction
8.0% of all CICLOPIROX OLAMINE reports
#2 most reported adverse reaction
DEVICE DISLOCATION is the #2 most commonly reported adverse reaction for CICLOPIROX OLAMINE, manufactured by Cosette Pharmaceuticals, Inc.. There are 78 FDA adverse event reports linking CICLOPIROX OLAMINE to DEVICE DISLOCATION. This represents approximately 8.0% of all 975 adverse event reports for this drug.
Patients taking CICLOPIROX OLAMINE who experience device dislocation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE DISLOCATION is moderately reported among CICLOPIROX OLAMINE users, representing a notable but not dominant share of adverse events.
In addition to device dislocation, the following adverse reactions have been reported for CICLOPIROX OLAMINE:
The following drugs have also been linked to device dislocation in FDA adverse event reports:
DEVICE DISLOCATION has been reported as an adverse event in 78 FDA reports for CICLOPIROX OLAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE DISLOCATION accounts for approximately 8.0% of all adverse event reports for CICLOPIROX OLAMINE, making it one of the most commonly reported side effect.
If you experience device dislocation while taking CICLOPIROX OLAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.